Bristol-Myers Squibb Company company logo
Bristol-Myers Squibb Company logo

Bristol-Myers Squibb Company (BMY) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$10.67B$186.00M-1.71%

Summary

Current Value
As of today, BMY annual cash & cash equivalents is $10.67B, down -1.71% on
Historical Performance
BMY annual cash & cash equivalents is up +13.53% over the past 3 years, down -35.47% over the past 5 years
All-Time High Comparison
BMY annual cash & cash equivalents is currently -38.52% below its historical high of $17.36B set on
3-Year Low Comparison
BMY annual cash & cash equivalents is +13.53% above its 3-year low of $9.40B reached on an earlier date
Sector Comparison
BMY annual cash & cash equivalents is higher than 99.32% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

BMY Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$10.67B-1.7%+13.5%-35.5%+46.2%
Quarterly Cash & Cash Equivalents$10.67B-1.7%+13.5%-35.5%+46.2%
Price$59.71-0.5%-10.3%-4.0%+134.8%
Annual Current Assets$29.39B-1.3%+7.8%-2.7%+121.4%
Annual Total Liabilities$71.53B-6.1%+8.9%-11.3%+363.4%
Annual Working Capital$5.97B-0.6%+11.0%-46.3%-8.6%
Annual Net Income$7.06B+179.0%+11.2%+178.4%+56.8%

Cash and Cash Equivalents Highs

BMY Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$12.34B-13.5%
5Y$17.36B-38.5%
All$17.36B-38.5%

Cash and Cash Equivalents Lows

BMY Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$9.40BN/A+13.5%
5Y$9.40B+13.5%
All$429.30M+2386.1%

Cash and Cash Equivalents History

YearValueChange
$10.67B-1.7%
$10.86B-12.0%
$12.34B+31.2%
$9.40B-45.8%
$17.36B+5.0%
$16.54B+7.4%
$15.39B+73.3%
$8.88B+30.4%
$6.81B+7.3%
$6.35B+48.7%
$4.27B-42.6%
$7.44B+64.3%
$4.53B+60.0%
$2.83B-67.6%
$8.73B+19.6%
$7.30B-14.2%
$8.51B+3.0%
$8.27B+271.5%
$2.23B-44.6%
YearValueChange
$4.01B-30.8%
$5.80B-22.4%
$7.47B+34.4%
$5.56B+39.4%
$3.99B-29.4%
$5.65B+67.0%
$3.39B+14.5%
$2.96B+16.9%
$2.53B+41.0%
$1.79B-17.9%
$2.19B+0.3%
$2.18B-20.2%
$2.73B+14.4%
$2.39B+21.8%
$1.96B+163.4%
$743.40M+21.6%
$611.60M+42.5%
$429.30M-

FAQ

  • What is the current annual cash & cash equivalents of BMY?

    As of today, BMY annual cash & cash equivalents is $10.67B

  • What is 1-year change in BMY annual cash & cash equivalents?

    BMY annual cash & cash equivalents is down -1.71% year-over-year

  • What is 3-year change in BMY annual cash & cash equivalents?

    BMY annual cash & cash equivalents is up +13.53% over the past 3 years

  • How far is BMY annual cash & cash equivalents from its all-time high?

    BMY annual cash & cash equivalents is currently -38.52% below its historical high of $17.36B set on December 31, 2021

  • How does BMY annual cash & cash equivalents rank versus sector peers?

    BMY annual cash & cash equivalents is higher than 99.32% of companies in Healthcare sector

  • When is BMY next annual earnings release?

    As of today, the next annual earnings release for BMY has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. BMY Official Website www.bms.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/14272/000001427226000002/0000014272-26-000002-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
  4. BMY Profile on Yahoo Finance finance.yahoo.com/quote/BMY
  5. BMY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmy